Management of Myopic Choroidal Neovascularization: Focus on Anti-VEGF Therapy.

Drugs

Singapore Eye Research Institute, Singapore National Eye Centre, 11 Third Hospital Avenue, Singapore, 168751, Singapore.

Published: July 2016

AI Article Synopsis

  • Myopic choroidal neovascularization (mCNV) is a serious eye condition that mainly affects younger patients with pathologic myopia and can significantly impact their quality of life.
  • Traditional treatments, like photodynamic therapy, have had limited success, leading to a search for more effective options.
  • Anti-vascular endothelial growth factor (anti-VEGF) therapy, previously used for age-related macular degeneration, has proven to be effective for mCNV and is now the preferred treatment method.

Article Abstract

Myopic choroidal neovascularization (mCNV) is the second most common form of CNV after age-related macular degeneration (AMD). It is a sight-threatening complication of pathologic myopia (PM) and often affects patients in their working years causing significant impact on quality of life. Previous therapies such as photodynamic therapy with verteporfin have shown limited success. Due to the similarities in pathogenesis of mCNV and AMD CNV, anti-vascular endothelial growth factor therapy (anti-VEGF), which has so far been the mainstay of treatment for AMD CNV, has been shown to be effective in the treatment of mCNV and has become the first-line treatment of choice. This article aims to examine briefly the epidemiology and pathophysiology of mCNV, as well as review the evidence for efficacy, safety, and clinical use of anti-VEGF treatment for mCNV.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-016-0605-0DOI Listing

Publication Analysis

Top Keywords

myopic choroidal
8
choroidal neovascularization
8
amd cnv
8
treatment mcnv
8
mcnv
5
management myopic
4
neovascularization focus
4
focus anti-vegf
4
anti-vegf therapy
4
therapy myopic
4

Similar Publications

The Effects of Nitric Oxide on Choroidal Gene Expression.

J Bioinform Syst Biol

January 2024

Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73104, United States.

Purpose: Nitric oxide (NO) is recognized as an important biological mediator that controls several physiological functions, and evidence is now emerging that this molecule may play a significant role in the postnatal control of ocular growth and myopia development. We therefore sought to understand the role that nitric oxide plays in visually-guided ocular growth in order to gain insight into the underlying mechanisms of this process.

Methods: Choroids were incubated in organ culture in the presence of the NO donor, PAPA- NONOate (1.

View Article and Find Full Text PDF

Clinical Features Evaluation of Myopic Fundus tessellation from OCTA and MfERG.

Photodiagnosis Photodyn Ther

January 2025

Ningbo Eye Hospital, Wenzhou Medical University, Ningbo, Zhejiang, 315000, P.R. China. Electronic address:

Purpose: To evaluate the differences in fundus tessellation among various severities using multifocal visual electrophysiology (MfERG) and optical coherence tomography angiography (OCTA) for clinical grading and treatment.

Methods: This study included 52 patients totaling 87 eyes. The Early Treatment Diabetic Retinopathy Study (ETDRS) grid division method was utilized to assess Grade of fundus tessellation.

View Article and Find Full Text PDF

The abnormal growth of irregular new blood vessels into the subretinal or intraretinal space is known as macular neovascularization (MNV). People over 50 are often affected by this disorder, which is typically brought on by age-related macular degeneration. In addition, MNV can be found in people under 50 years of age, who may present primary ophthalmic diseases such as pathological myopia, angioid streaks, traumatic choroidal rupture, or suspected ocular histoplasmosis syndrome.

View Article and Find Full Text PDF

The clinical effects and mechanism of action of ranibizumab in treating myopic choroidal neovascularization.

Int Ophthalmol

January 2025

Department of Ophthalmology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, 215008, Jiangsu, China.

Purpose: Myopic choroidal neovascularization (CNV) is a common reason for visual impairment. This study investigated the clinical effects of repeated intravitreal injections of ranibizumab among patients with CNV secondary to pathologic myopia.

Methods: This study involved a single-center, non-randomized clinical prospective cohort research design including 39 patients with myopic CNV and a control group of 10 patients with cataract.

View Article and Find Full Text PDF

What is the relationship between the choroidal vascularity ındex (CVI) and myopia?

Int Ophthalmol

January 2025

Department of Ophthalmology, Faculty of Medicine, Hitit University, Çorum, Turkey.

Purpose: To examine the detailed vascular and morphological characteristics of the choroidal tissue in subjects with myopia.

Methods: A total of 111 subjects with myopia were included in the study. The study was conducted in three groups according to spherical equivalent(SE).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!